It is notable that the debate between the association of ACE I/D and AD and the corresponding debate between the opposing natures of ACE (and Ang II) on the central nervous system is mirrored in the current debate over the clinical use of ACE inhibitors (ACE-Is) in AD beyond their role as a treatment for hypertension. This evidence concerns the gene ACE and hypertensive disorder.